相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。NK cell detachment from target cells is regulated by successful cytotoxicity and influences cytokine production
Moritz Anft et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Immune Response Dysfunction in Chronic Lymphocytic Leukemia: Dissecting Molecular Mechanisms and Microenvironmental Conditions
Francesca Arruga et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Multiple actin networks coordinate mechanotransduction at the immunological synapse
Daniel Blumenthal et al.
JOURNAL OF CELL BIOLOGY (2020)
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Rewired signaling network in T cells expressing the chimeric antigen receptor (CAR)
Rui Dong et al.
EMBO JOURNAL (2020)
Escape of tumor cells from the NK cell cytotoxic activity
Claudia Cantoni et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2020)
Combination lenalidomide-rituximab immunotherapy activates anti-tumour immunity and induces tumour cell death by complementary mechanisms of action in follicular lymphoma
Hsiling Chiu et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
17p deletion strongly influences rituximab elimination in chronic lymphocytic leukemia
Cristina Bagacean et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Chronic lymphocytic leukaemia: from genetics to treatment
Francesc Bosch et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
State-of-the-art for CAR T-cell therapy for chronic lymphocytic leukemia in 2019
Richard Lemal et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Engaging Cytotoxic T and NK Cells for Immunotherapy in Chronic Lymphocytic Leukemia
Tom Hofland et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The pharmalogical reactivation of p53 function improves breast tumor cell lysis by granzyme B and NK cells through induction of autophagy
Marie Chollat-Namy et al.
CELL DEATH & DISEASE (2019)
Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune checkpoint CD200
Daruka Mahadevan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Emerging treatment options for patients with p53-pathway-deficient CLL
Marisa J. L. Aitken et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2019)
Resistance Mechanisms to Targeted Agents in Chronic Lymphocytic Leukemia
Adam S. Kittai et al.
CANCER JOURNAL (2019)
Natural Killer Cell Hypo-responsiveness in Chronic Lymphocytic Leukemia can be Circumvented In Vitro by Adequate Activating Signaling
Tom Hofland et al.
HEMASPHERE (2019)
Dual PD1/LAG3 immune checkpoint blockade limits tumor development in a murine model of chronic lymphocytic leukemia
Marina Wierz et al.
BLOOD (2018)
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation
J. Malcikova et al.
LEUKEMIA (2018)
Immunological Synapse Predicts Effectiveness of Chimeric Antigen Receptor Cells
Wei Xiong et al.
MOLECULAR THERAPY (2018)
Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity
A. J. Davenport et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
High-dimensional mass cytometry analysis revealed microenvironment complexity in chronic lymphocytic leukemia
Marina Wierz et al.
ONCOIMMUNOLOGY (2018)
Actin Cytoskeleton Remodeling Drives Breast Cancer Cell Escape from Natural Killer-Mediated Cytotoxicity
Antoun Al Absi et al.
CANCER RESEARCH (2018)
TP53 aberrations in chronic lymphocytic leukemia: an overview of the clinical implications of improved diagnostics
Elias Campo et al.
HAEMATOLOGICA (2018)
Chronic lymphocytic leukemia treatment algorithm 2018
Sameer A. Parikh
BLOOD CANCER JOURNAL (2018)
Expanding the Therapeutic Window for CAR T Cell Therapy in Solid Tumors: The Knowns and Unknowns of CAR T Cell Biology
Keisuke Watanabe et al.
FRONTIERS IN IMMUNOLOGY (2018)
Ig-Like Transcript 2 (ILT2) Blockade and Lenalidomide Restore NK Cell Function in Chronic Lymphocytic Leukemia
Monica Villa-Alvarez et al.
FRONTIERS IN IMMUNOLOGY (2018)
Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance)
John C. Byrd et al.
BLOOD ADVANCES (2018)
T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers
Marzia Palma et al.
HAEMATOLOGICA (2017)
T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers
Marzia Palma et al.
HAEMATOLOGICA (2017)
Lenalidomide in the treatment of chronic lymphocytic leukemia
Gilad Itchaki et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
Quantitative Imaging Approaches to Study the CAR Immunological Synapse
Malini Mukherjee et al.
MOLECULAR THERAPY (2017)
Mechanisms of Immune Tolerance in Leukemia and Lymphoma
Emily K. Curran et al.
TRENDS IN IMMUNOLOGY (2017)
Gene-modified NK-92MI cells expressing a chimeric CD16-BB-ζ or CD64-BB-ζ receptor exhibit enhanced cancer-killing ability in combination with therapeutic antibody
Ying Chen et al.
ONCOTARGET (2017)
Human Leukocyte Antigen-G Inhibits the Anti-Tumor Effect of Natural Killer Cells via Immunoglobulin-Like Transcript 2 in Gastric Cancer
Rui Wan et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Chronic lymphocytic leukemia (CLL)Then and now
Kanti R. Rai et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
The cytotoxic T lymphocyte immune synapse at a glance
Nele M. G. Dieckmann et al.
JOURNAL OF CELL SCIENCE (2016)
Chk1 inhibition significantly potentiates activity of nucleoside analogs in TP53-mutated B-lymphoid cells
Jana Zemanova et al.
ONCOTARGET (2016)
Phenotypic alteration of CD8+ T cells in chronic lymphocytic leukemia is associated with epigenetic reprogramming
Jiazhu Wu et al.
ONCOTARGET (2016)
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia
Rebecca Voltan et al.
ONCOTARGET (2016)
Human Cytotoxic T Lymphocytes Form Dysfunctional Immune Synapses with B Cells Characterized by Non-Polarized Lytic Granule Release
Anna Kabanova et al.
CELL REPORTS (2016)
Activated Allogeneic NK Cells Preferentially Kill Poor Prognosis B-Cell Chronic Lymphocytic Leukemia Cells
Diego Sanchez-Martinez et al.
FRONTIERS IN IMMUNOLOGY (2016)
Therapeutic CD94/NKG2A blockade improves natural killer cell dysfunction in chronic lymphocytic leukemia
Emily M. McWilliams et al.
ONCOIMMUNOLOGY (2016)
Expression of Programmed Death 1 Ligand in Different Compartments of Chronic Lymphocytic Leukemia
Maciej Grzywnowicz et al.
ACTA HAEMATOLOGICA (2015)
Targeted therapies in CLL: mechanisms of resistance and strategies for management
Jennifer A. Woyach et al.
BLOOD (2015)
Perturbation of the normal immune system in patients with CLL
Francesco Forconi et al.
BLOOD (2015)
Monoclonal antibodies to HLA-E bind epitopes carried by unfolded beta(2)m-free heavy chains
Elisa Tremante et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Cdc42 induces EGF receptor protein accumulation and promotes EGF receptor nuclear transport and cellular transformation
Xiao-Yu Wang et al.
FEBS LETTERS (2015)
CMV-specific CD8+ T-cell function is not impaired in chronic lymphocytic leukemia
G. Doreen te Raa et al.
BLOOD (2014)
HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism
Roberta Rizzo et al.
HAEMATOLOGICA (2014)
Targeting the actin cytoskeleton: selective antitumor action via trapping PKCε
F. Foerster et al.
CELL DEATH & DISEASE (2014)
Lenalidomide Induces Immunomodulation in Chronic Lymphocytic Leukemia and Enhances Antitumor Immune Responses Mediated by NK and CD4 T Cells
Andrea Acebes-Huerta et al.
BIOMED RESEARCH INTERNATIONAL (2014)
T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production
John C. Riches et al.
BLOOD (2013)
Classification of human natural killer cells based on migration behavior and cytotoxic response
Bruno Vanherberghen et al.
BLOOD (2013)
A Novel Class of Anticancer Compounds Targets the Actin Cytoskeleton in Tumor Cells
Justine R. Stehn et al.
CANCER RESEARCH (2013)
Aggressive disease defined by cytogenetics is associated with cytokine dysregulation in CLL/SLL patients
Reem Karmali et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Small molecule targeting Cdc42-intersectin interaction disrupts Golgi organization and suppresses cell motility
Amy Friesland et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Genetic and Environmental Determinants of Human NK Cell Diversity Revealed by Mass Cytometry
Amir Horowitz et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer
Alan G. Ramsay et al.
BLOOD (2012)
Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: a dominant role of CCL2
Angela Schulz et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
ILT2/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse
Benoit Favier et al.
FASEB JOURNAL (2010)
Cytotoxic immunological synapses
Michael L. Dustin et al.
IMMUNOLOGICAL REVIEWS (2010)
TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutations
T. Zenz et al.
LEUKEMIA (2010)
The kinase inhibitor dasatinib induces apoptosis in chronic lymphocytic leukemia cells in vitro with preference for a subgroup of patients with unmutated IgVHgenes
Aditya Veldurthy et al.
BLOOD (2008)
The immunodeficiency of chronic lymphocytic leukaemia
A. D. Hamblin et al.
BRITISH MEDICAL BULLETIN (2008)
Resistance of Tumor Cells to Cytolytic T Lymphocytes Involves Rho-GTPases and Focal Adhesion Kinase Activation
Soraya Abouzahr-Rifai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G
G. Maki et al.
LEUKEMIA (2008)
Lifeact: a versatile marker to visualize F-actin
Julia Riedl et al.
NATURE METHODS (2008)
Formation and function of the lytic NK-cell immunological synapse
Jordan S. Orange
NATURE REVIEWS IMMUNOLOGY (2008)
Identification of target actin content and polymerization status as a mechanism of tumor resistance after cytolytic T lymphocyte pressure
S Abouzahr et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia
H Nückel et al.
BLOOD (2005)
Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy
H Guven et al.
LEUKEMIA (2003)
Expansion of CMV-specific CD8+CD45RA+CD27- T cells in B-cell chronic lymphocytic leukemia
WJM Mackus et al.
BLOOD (2003)
分享论文
